BSE Live
Nov 07, 16:01Prev. Close
2309.35
Open Price
2289.95
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Nov 07, 15:58Prev. Close
2309.10
Open Price
2250.00
Bid Price (Qty.)
2261.80 (15)
Offer Price (Qty.)
0.00 (0)
| Key Financial Ratios of Mankind Pharma (in Rs. Cr.) | Mar 20 | Mar 19 | Mar 18 | Mar 17 | Mar 16 | |
| Per Share Ratios | ||||||
| Basic EPS (Rs.) | 23.92 | 12.83 | 17.33 | 268.71 | 234.25 | |
| Diluted EPS (Rs.) | 23.92 | 12.83 | 17.33 | 268.71 | 234.25 | |
| Cash EPS (Rs.) | 25.46 | 13.79 | 18.02 | 278.00 | 252.57 | |
| Book Value [ExclRevalReserve]/Share (Rs.) | 91.15 | 76.51 | 74.81 | 1,317.41 | 1,031.78 | |
| Book Value [InclRevalReserve]/Share (Rs.) | 91.15 | 76.51 | 74.81 | 1,317.41 | 1,031.78 | |
| Dividend / Share(Rs.) | 7.55 | 0.04 | 7.50 | 0.00 | 150.00 | |
| Revenue from Operations/Share (Rs.) | 119.68 | 96.79 | 97.81 | 1,750.95 | 1,572.44 | |
| PBDIT/Share (Rs.) | 33.38 | 19.19 | 24.42 | 400.21 | 355.38 | |
| PBIT/Share (Rs.) | 31.84 | 18.23 | 23.73 | 390.93 | 337.05 | |
| PBT/Share (Rs.) | 31.58 | 17.26 | 23.28 | 390.23 | 336.33 | |
| Net Profit/Share (Rs.) | 23.92 | 12.83 | 17.33 | 268.71 | 234.25 | |
| Profitability Ratios | ||||||
| PBDIT Margin (%) | 27.89 | 19.82 | 24.96 | 22.85 | 22.60 | |
| PBIT Margin (%) | 26.60 | 18.83 | 24.26 | 22.32 | 21.43 | |
| PBT Margin (%) | 26.38 | 17.82 | 23.80 | 22.28 | 21.38 | |
| Net Profit Margin (%) | 19.98 | 13.25 | 17.72 | 15.34 | 14.89 | |
| Return on Networth / Equity (%) | 26.24 | 16.77 | 23.16 | 20.39 | 22.70 | |
| Return on Capital Employed (%) | 34.33 | 23.36 | 31.07 | 28.95 | 32.43 | |
| Return on Assets (%) | 21.14 | 13.27 | 17.24 | 16.97 | 18.94 | |
| Total Debt/Equity (X) | 0.00 | 0.06 | 0.12 | 0.00 | 0.00 | |
| Asset Turnover Ratio (%) | 1.14 | 0.98 | 1.09 | 1.24 | 1.20 | |
| Liquidity Ratios | ||||||
| Current Ratio (X) | 2.39 | 1.88 | 2.34 | 3.94 | 3.24 | |
| Quick Ratio (X) | 1.73 | 1.23 | 1.85 | 2.82 | 2.21 | |
| Inventory Turnover Ratio (X) | 0.86 | 0.46 | 0.28 | 0.27 | 0.30 | |
| Dividend Payout Ratio (NP) (%) | 31.56 | 4.67 | 43.26 | 0.00 | 64.03 | |
| Dividend Payout Ratio (CP) (%) | 29.65 | 4.35 | 41.61 | 0.00 | 59.38 | |
| Earnings Retention Ratio (%) | 68.44 | 95.33 | 56.74 | 0.00 | 35.97 | |
| Cash Earnings Retention Ratio (%) | 70.35 | 95.65 | 58.39 | 0.00 | 40.62 | |
| Valuation Ratios | ||||||
| Enterprise Value (Cr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| EV/Net Operating Revenue (X) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| EV/EBITDA (X) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| MarketCap/Net Operating Revenue (X) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Retention Ratios (%) | 68.43 | 95.32 | 56.73 | 0.00 | 35.96 | |
| Price/BV (X) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Price/Net Operating Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Earnings Yield | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
07.11.2025
Mankind Pharma Consolidated September 2025 Net Sales at Rs 3,697.16 crore, up 20.17% Y-o-Y
07.11.2025
13.10.2025
19.09.2025
07.11.2025
Mankind Pharma Consolidated September 2025 Net Sales at Rs 3,697.16 crore, up 20.17% Y-o-Y
01.08.2025
Mankind Pharma Consolidated June 2025 Net Sales at Rs 3,570.35 crore, up 23.4% Y-o-Y
01.08.2025
Mankind Pharma Standalone June 2025 Net Sales at Rs 2,541.36 crore, up 5.75% Y-o-Y
24.06.2025
Mankind Pharma Consolidated March 2025 Net Sales at Rs 3,079.37 crore, up 26.15% Y-o-Y